110 related articles for article (PubMed ID: 14681327)
1. Gastrointestinal stromal tumors with internal tandem duplications in 3' end of KIT juxtamembrane domain occur predominantly in stomach and generally seem to have a favorable course.
Lasota J; Dansonka-Mieszkowska A; Stachura T; Schneider-Stock R; Kallajoki M; Steigen SE; Sarlomo-Rikala M; Boltze C; Kordek R; Roessner A; Stachura J; Miettinen M
Mod Pathol; 2003 Dec; 16(12):1257-64. PubMed ID: 14681327
[TBL] [Abstract][Full Text] [Related]
2. Mutations in exon 11 of c-Kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas.
Lasota J; Jasinski M; Sarlomo-Rikala M; Miettinen M
Am J Pathol; 1999 Jan; 154(1):53-60. PubMed ID: 9916918
[TBL] [Abstract][Full Text] [Related]
3. Mutations in exons 9 and 13 of KIT gene are rare events in gastrointestinal stromal tumors. A study of 200 cases.
Lasota J; Wozniak A; Sarlomo-Rikala M; Rys J; Kordek R; Nassar A; Sobin LH; Miettinen M
Am J Pathol; 2000 Oct; 157(4):1091-5. PubMed ID: 11021812
[TBL] [Abstract][Full Text] [Related]
4. Mutations in c-kit gene exons 9 and 13 in gastrointestinal stromal tumors among Japanese.
Sakurai S; Oguni S; Hironaka M; Fukayama M; Morinaga S; Saito K
Jpn J Cancer Res; 2001 May; 92(5):494-8. PubMed ID: 11376557
[TBL] [Abstract][Full Text] [Related]
5. Frequent occurrence of low grade cases among metastatic gastrointestinal stromal tumours.
Tornóczky T; Kövér E; Pajor L
J Clin Pathol; 2003 May; 56(5):363-7. PubMed ID: 12719457
[TBL] [Abstract][Full Text] [Related]
6. Gastric schwannoma: a clinicopathologic study of 51 cases and critical review of the literature.
Voltaggio L; Murray R; Lasota J; Miettinen M
Hum Pathol; 2012 May; 43(5):650-9. PubMed ID: 22137423
[TBL] [Abstract][Full Text] [Related]
7. P53 expression is significantly correlated with high risk of malignancy and epithelioid differentiation in GISTs. An immunohistochemical study of 104 cases.
Pauser U; Schmedt Auf der Günne N; Klöppel G; Merz H; Feller AC
BMC Cancer; 2008 Jul; 8():204. PubMed ID: 18651966
[TBL] [Abstract][Full Text] [Related]
8. Metachronous Gastrointestinal Stromal Tumors of Different Histologies: An Unusual Case.
Nudotor R; Ali AM; Weltz A; Park A; Gibson G
Cureus; 2024 Apr; 16(4):e59159. PubMed ID: 38803754
[TBL] [Abstract][Full Text] [Related]
9. Mucosal Schwann cell hamartoma: a benign and little-known entity.
Mauriz Barreiro V; Ramos Alonso M; Fernández López M; Rivera Castillo DA; Durana Tonder C; Pradera Cibreiro C
Rev Esp Enferm Dig; 2024 Apr; 116(4):223-224. PubMed ID: 37114421
[TBL] [Abstract][Full Text] [Related]
10. Molecular landscape and clinical significance of exon 11 mutations in KIT gene among patients with gastrointestinal stromal tumor: a retrospective exploratory study.
Zhao R; An T; Liu M; Zhou Y; Li R; Jiang G; Li J; Cao X; Zong H
Front Oncol; 2023; 13():1272046. PubMed ID: 37901323
[TBL] [Abstract][Full Text] [Related]
11. Impact of the KIT/PDGFRA genotype on prognosis in imatinib-naïve Japanese patients with gastrointestinal stromal tumor.
Cho H; Nishida T; Takahashi T; Masuzawa T; Hirota S
Ann Gastroenterol Surg; 2022 Mar; 6(2):241-248. PubMed ID: 35261949
[TBL] [Abstract][Full Text] [Related]
12. Perspectives on the evolving state of the art management of gastrointestinal stromal tumours.
Szucs Z; Jones RL
Transl Gastroenterol Hepatol; 2018; 3():21. PubMed ID: 29780899
[TBL] [Abstract][Full Text] [Related]
13. Unraveling the spectrum of
Pai T; Bal M; Shetty O; Gurav M; Ostwal V; Ramaswamy A; Ramadwar M; Desai S
South Asian J Cancer; 2017; 6(3):113-117. PubMed ID: 28975118
[TBL] [Abstract][Full Text] [Related]
14. Molecular and functional characterization of a new 3' end KIT juxtamembrane deletion in a duodenal GIST treated with neoadjuvant Imatinib.
Perfetti V; Laurini E; Aulić S; Fermeglia M; Riboni R; Lucioni M; Dallera E; Delfanti S; Pugliese L; Latteri FS; Pietrabissa A; Pricl S
Oncotarget; 2017 Aug; 8(34):56158-56167. PubMed ID: 28915580
[TBL] [Abstract][Full Text] [Related]
15. GIST Manifesting as a Retroperitoneal Tumor: Clinicopathologic Immunohistochemical, and Molecular Genetic Study of 112 Cases.
Miettinen M; Felisiak-Golabek A; Wang Z; Inaguma S; Lasota J
Am J Surg Pathol; 2017 May; 41(5):577-585. PubMed ID: 28288036
[TBL] [Abstract][Full Text] [Related]
16. Analysis of mutation of the c-Kit gene and
Xu CW; Lin S; Wang WL; Gao WB; Lv JY; Gao JS; Zhang LY; Li Y; Wang L; Zhang YP; Tian YW
Exp Ther Med; 2015 Sep; 10(3):1045-1051. PubMed ID: 26622437
[TBL] [Abstract][Full Text] [Related]
17. Gastrointestinal stromal tumor - an evolving concept.
Tornillo L
Front Med (Lausanne); 2014; 1():43. PubMed ID: 25593916
[TBL] [Abstract][Full Text] [Related]
18. AMACR amplification and overexpression in primary imatinib-naïve gastrointestinal stromal tumors: a driver of cell proliferation indicating adverse prognosis.
Li CF; Chen LT; Lan J; Chou FF; Lin CY; Chen YY; Chen TJ; Li SH; Yu SC; Fang FM; Tai HC; Huang HY
Oncotarget; 2014 Nov; 5(22):11588-603. PubMed ID: 25473890
[TBL] [Abstract][Full Text] [Related]
19. SKP2 high expression, KIT exon 11 deletions, and gastrointestinal bleeding as predictors of poor prognosis in primary gastrointestinal stromal tumors.
Lv A; Li Z; Tian X; Guan X; Zhao M; Dong B; Hao C
PLoS One; 2013; 8(5):e62951. PubMed ID: 23690967
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
